TRAVERE THERAPEUTICS, INC. Labor and Related Expense
TRAVERE THERAPEUTICS, INC. (TVTX) reported Labor and Related Expense of $3.85 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LaborAndRelatedExpense · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. labor and related expense for the quarter ending 2014-06-30 was $3.85M, a 974.33% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. labor and related expense for the quarter ending 2014-03-31 was $2.08M, a 123.97% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. labor and related expense for the quarter ending 2013-06-30 was $358.17K.
- TRAVERE THERAPEUTICS, INC. labor and related expense for the quarter ending 2013-03-31 was $930.29K.
- TRAVERE THERAPEUTICS, INC. labor and related expense for fiscal 2013 was $4.27M, a 76.43% decline from fiscal 2012.
- TRAVERE THERAPEUTICS, INC. labor and related expense for fiscal 2012 was $18.13M.
| Period end | Labor and Related Expense 3 month | Labor and Related Expense 6 month | Labor and Related Expense 12 month | Labor and Related Expense 34 month |
|---|---|---|---|---|
| 2014-06-30 | $3.85M 10-Q · filed 2014-08-14 | $5.93M 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | $2.08M 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | $4.27M 10-K/A · filed 2015-07-09 | $24.73M 10-K/A · filed 2015-07-09 | ||
| 2013-06-30 | $358.17K 10-Q · filed 2014-08-14 | $1.29M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $930.29K 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | $18.13M 10-K/A · filed 2015-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |